481 related articles for article (PubMed ID: 36671446)
21. Current paradigms in epigenetic anticancer therapeutics and future challenges.
Singh M; Kumar V; Sehrawat N; Yadav M; Chaudhary M; Upadhyay SK; Kumar S; Sharma V; Kumar S; Dilbaghi N; Sharma AK
Semin Cancer Biol; 2022 Aug; 83():422-440. PubMed ID: 33766649
[TBL] [Abstract][Full Text] [Related]
22. Cancer epigenetics: Moving forward.
Nebbioso A; Tambaro FP; Dell'Aversana C; Altucci L
PLoS Genet; 2018 Jun; 14(6):e1007362. PubMed ID: 29879107
[TBL] [Abstract][Full Text] [Related]
23. Neuroblastoma and the epigenome.
Fetahu IS; Taschner-Mandl S
Cancer Metastasis Rev; 2021 Mar; 40(1):173-189. PubMed ID: 33404859
[TBL] [Abstract][Full Text] [Related]
24. DNA methylation as a target of epigenetic therapeutics in cancer.
Li KK; Li F; Li QS; Yang K; Jin B
Anticancer Agents Med Chem; 2013 Feb; 13(2):242-7. PubMed ID: 22934696
[TBL] [Abstract][Full Text] [Related]
25. Clinical advances in targeting epigenetics for cancer therapy.
Feng S; De Carvalho DD
FEBS J; 2022 Mar; 289(5):1214-1239. PubMed ID: 33545740
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic Targets and their Inhibitors in Cancer Therapy.
Zhao L; Duan YT; Lu P; Zhang ZJ; Zheng XK; Wang JL; Feng WS
Curr Top Med Chem; 2018; 18(28):2395-2419. PubMed ID: 30582481
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic-based therapies in cancer: progress to date.
Song SH; Han SW; Bang YJ
Drugs; 2011 Dec; 71(18):2391-403. PubMed ID: 22141383
[TBL] [Abstract][Full Text] [Related]
28. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
Dobosy JR; Roberts JL; Fu VX; Jarrard DF
J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
[TBL] [Abstract][Full Text] [Related]
29. Clinical advances in hypomethylating agents targeting epigenetic pathways.
Cang S; Lu Q; Ma Y; Liu D
Curr Cancer Drug Targets; 2010 Aug; 10(5):539-45. PubMed ID: 20384584
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic modifications in prostate cancer.
Ngollo M; Dagdemir A; Karsli-Ceppioglu S; Judes G; Pajon A; Penault-Llorca F; Boiteux JP; Bignon YJ; Guy L; Bernard-Gallon DJ
Epigenomics; 2014; 6(4):415-26. PubMed ID: 25333850
[TBL] [Abstract][Full Text] [Related]
31. Somatic alterations and dysregulation of epigenetic modifiers in cancers.
Aumann S; Abdel-Wahab O
Biochem Biophys Res Commun; 2014 Dec; 455(1-2):24-34. PubMed ID: 25111821
[TBL] [Abstract][Full Text] [Related]
32. Epigenetics, disease, and therapeutic interventions.
Lu Q; Qiu X; Hu N; Wen H; Su Y; Richardson BC
Ageing Res Rev; 2006 Nov; 5(4):449-67. PubMed ID: 16965942
[TBL] [Abstract][Full Text] [Related]
33. Epigenetics of osteoarticular diseases: recent developments.
Roberts SB; Wootton E; De Ferrari L; Albagha OM; Salter DM
Rheumatol Int; 2015 Aug; 35(8):1293-305. PubMed ID: 25812537
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
35. Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer.
Falahi F; van Kruchten M; Martinet N; Hospers GA; Rots MG
Breast Cancer Res; 2014 Jul; 16(4):412. PubMed ID: 25410383
[TBL] [Abstract][Full Text] [Related]
36. Epigenetics and cancer, 2nd IARC meeting, Lyon, France, 6 and 7 December 2007.
Lambert MP; Herceg Z
Mol Oncol; 2008 Jun; 2(1):33-40. PubMed ID: 19383327
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic alterations in cancer.
Ilango S; Paital B; Jayachandran P; Padma PR; Nirmaladevi R
Front Biosci (Landmark Ed); 2020 Mar; 25(6):1058-1109. PubMed ID: 32114424
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic tools (The Writers, The Readers and The Erasers) and their implications in cancer therapy.
Biswas S; Rao CM
Eur J Pharmacol; 2018 Oct; 837():8-24. PubMed ID: 30125562
[TBL] [Abstract][Full Text] [Related]
39. Advances in the Delivery and Development of Epigenetic Therapeutics for the Treatment of Cancer.
Ghosh A; Himaja A; Biswas S; Kulkarni O; Ghosh B
Mol Pharm; 2023 Dec; 20(12):5981-6009. PubMed ID: 37899551
[TBL] [Abstract][Full Text] [Related]
40. Compendium of aberrant DNA methylation and histone modifications in cancer.
Hattori N; Ushijima T
Biochem Biophys Res Commun; 2014 Dec; 455(1-2):3-9. PubMed ID: 25194808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
